Latest edition of the Journal of Neuromuscular Diseases now online – Jun 2020

A new issue of the Journal of Neuromuscular Diseases has recently been released. Read it below:

Journal of Neuromuscular Diseases: Volume 7, issue 3

(click to view it at the journal website)

*Hanns is joint editor-in-chief of the Journal of Neuromuscular Diseases, together with Carsten Bönnemann of the NIH National Institute of Neurological Disorders and Stroke.

 

Articles in this issue:

(click to view all)

  • Is gene size an issue for the diagnosis of skeletal muscle disorders?
  • Clinical phenotypes of DMD exon 51 skip equivalent deletions: A systematic review
  • Blood-derived biomarkers correlate with clinical progression in Duchenne muscular dystrophy
  • Evaluation of genotypes and epidemiology of spinal muscular atrophy in Greece: A nationwide study spanning 24 years
  • Prospective cohort study of nusinersen treatment in adults with spinal muscular atrophy
  • Retrospective analysis of exulizumab in partients with acetylcholine receptor antibody-negative myasthenia gravis: A case series
  • Laboratory tests for neuropathies: What to do and to avoid
  • Dysphagia and dysarthria in children with neuromuscular diseases, a prevalance study
  • Myasthenia gravis impairment index: Sensitivity for change in generalized muscle weakness
  • Confirmation of TAC01 as a Leigh syndrome disease gene in two additional families
  • Carey-Fineman-Ziter syndrome: A MYMK-related myopathy mimicking brainstem dysgensis
  • Blood flow to the spleen is altered in a mouse model of spinal muscular atrophy
  • Feeding and swallowing problems in infants with spinal muscular atrophy type 1: An observational study
  • Assessing physical activity using accelerometers in youth with Duchenne muscular dystrophy
  • Rehabilitation following fracture in dystrophinopathy, a case series
  • Chronic progressive external ophthalmoplegia due to a rare de novo m.12334G>A MT-TL2 mitochondrial DNA variant
  • COVID-19 in refractory myasthenia gravis – A case report of successful outcome
  • Myotubular trust – 2020 call for projects (open to international applications)
Journal of Neuromuscular Diseases

Read next...

Text reading: Solve-RD publication: Solve-RD flagship publication: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses. Photos of Dr Kiran Polavarapu, Dr Rachel Thompson, Dr Hanns Lochmüller.

Solve-RD flagship publication in Nature Medicine: Genomic reanalysis of a pan-European rare-disease resource yields new diagnoses

Patients and families with rare disorders often remain without a genetic diagnosis despite modern advances in diagnostic testing. Due to the rarity and global distribution...
New publication: Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis . Author's photos on the right, diagram from paper underneath title.

New Lab Publication Identifies Novel ATP2A2 Variant as Genetic Cause of Dominant Rhabdomyolysis

Rhabdomyolysis is an acute failure of cellular homeostasis characterized by acute skeletal muscle damage triggered by trauma, infection, drugs, or strenuous exercise. Recurrent rhabdomyolysis is...
New lab publication on riboflavin transporter deficiency model

New Publication: Development of a riboflavin-responsive model of riboflavin transporter deficiency in zebrafish

Riboflavin transporter deficiency (RTD) is a rare genetic disorder in children, characterised by progressive sensorimotor and cranial neuronopathy caused by mutations in riboflavin transporter protein-encoding...
Congratulations CNMD Ottawa on 25 years of neuromuscular research. Photo of all former and current directors of the Centre.

uOttawa Eric Poulin Centre for Neuromuscular Disease Celebrates 25 Years of Neuromuscular Research

New co-directors Dr Mireille Khacho and Dr Hanns Lochmüller begin their tenure On November 25th the University of Ottawa Eric Poulin Centre for Neuromuscular Disease...
Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study

Canadian Patient Dosed in Argenx DOK7-CMS Study

Our clinical research team at the NeuroMuscular centre of The Ottawa Hospital is excited to share that a Canadian patient affected by DOK-7 Congenital Myasthenic...
New lab publication - Brain malformations and seizures by impaired chaperonin function of TRiC

New Publication: Brain malformations and seizures by impaired chaperonin function of TRiC

We are excited to share a new publication from our research team! The study “Brain malformations and seizures by impaired chaperonin function of TRiC” uncovers...